Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-13 | New | $22,999,999 | $22,999,999 | Equity Only | 06b | SEC link |
| 2024-03-13 | New | $31,112,518 | $31,112,518 | Equity Only | 06b | SEC link |
| 2022-08-24 | Amended | $6,999,997 | $0 | Equity Only | 06b | SEC link |
| 2021-08-31 | New | $6,999,997 | $6,999,997 | Equity Only | SEC link | |
| 2021-01-22 | New | $14,999,997 | $14,999,997 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jessica Alston | Director |
| Richard Batycky | Director, Executive |
| Bridget M. Cole | Executive |
| Peter Courossi | Executive |
| Freddie Dear | Director |
| James Ellis | Executive |
| Meredith Fisher | Director |
| Matthew Frankel | Executive |
| Jonathan Garen | Executive |
| Julie Grant | Director |
| Michael Higgins | Director |
| Rosy Hu | Director |
| Michael Lipp | Executive |
| Vijay Murthy | Director |
| Pini Orbach | Director |
| Christopher Silber | Executive |
| Bernard Silverman | Executive |